Posted inComunicati
Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE SUZHOU, China and MÖLNDAL, Sweden, May 28, 2026 /PRNewswire/ --…
Continue Reading














